Pfizer Inc. has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a review of interim data showed that the drug was not better than standard chemotherapy.
127904
Pfizer ends clinical trial
32522
Cancer drugs sold off by trust in short supply
39357
Dietary supplements may have an adverse effect on chemotherapy treatments
158466
Teva terminates partnership with CureTech
64372
Pfizer halts enrollment in lung cancer trial
156830
Boston Scientific PREVAIL trial meets two out of three co-primary endpoints
153612
Antisoma starts phase IIb trial of AS1411
37199
Bionovo (bnvi) to present positive results from phase 2 trial of Menerba
110630
AM Best withdraws Ratings of
38108
Drug for bones helps keep breast cancer from spreading
16512
Nexavar in Combination with Chemotherapy Shown to Extend...
75564
Pfizer pays out to doctors, researchers
85026
Breast cancer drug not living up to expectations
73557
Obesity drug sails through trials
91984
Researchers developing new methods to treat advanced prostate cancer
9895
New compounds kill ovarian, testicular, head and neck cancer cells with less toxicity
137890
Anti-cancer drug for women weakens bones